TB-500 is sold online as a research peptide, usually as freeze-dried powder in 2, 5 or 10 mg vials. Our current pick is SwissChems, which sells TB-500 and a BPC-157 + TB-500 blend with lot-specific lab reports. Before you buy, know what the evidence actually is: in July 2026 the FDA found no human studies or human exposure data for TB-500 itself. Here is what TB-500 is, what is and isn’t known, and what to check in a seller.

What is TB-500?

TB-500 is a short synthetic peptide based on a fragment of thymosin beta-4, a protein found in most cells that is involved in cell movement and tissue repair. It is not the same molecule as full-length thymosin beta-4, and results for one don’t automatically apply to the other.

  • Human evidence for TB-500: none completed. The FDA’s July 2026 review found no clinical studies or human exposure data. A first phase 1/2 trial of TB-500 was registered in 2026 and is recruiting.
  • Full-length thymosin beta-4 has been tested in people as eye drops (up to phase 3) and by intravenous infusion (phase 1). In a small phase 3 trial in a corneal condition, healing trended faster than placebo (6 of 10 vs 1 of 8, not statistically significant).
  • Lab and animal data: in cell tests, a TB-500 breakdown product (not TB-500 itself) sped up wound closure. The FDA found no nonclinical studies showing TB-500 itself promotes wound healing.

Full details, with sources: our TB-500 fact sheet.

Why TB-500 is often sold with BPC-157

Shops and forums often pair TB-500 with BPC-157, and some sell them blended in one vial. The idea is that the two act on repair in different ways. That combination has not been tested in people, and neither peptide has completed human trials as an injected product. The FDA’s July 2026 briefing also recorded one report of skin and gum darkening in someone using a “research use” product containing both peptides; which one caused it is unclear.

Is TB-500 safe?

Safety in people is not established. The FDA’s concerns include impurities and aggregation in injected peptides that could trigger immune reactions, and products sold as “TB-500” that contain a different molecule or salt from the one on the label. TB-500 is also prohibited at all times in sport (WADA S2, thymosin beta-4 and its derivatives).

What to look for when buying TB-500 online

  • A third-party report for your lot, showing identity (mass spectrometry) and purity (HPLC), with the lab and date. Because different molecules are sold under the TB-500 name, identity matters as much as purity.
  • Freeze-dried powder, sealed, with the amount per vial on the label.
  • Storage guidance. Peptides degrade with heat, light and repeated freezing and thawing.
  • No health claims on the product page.

Where to buy TB-500 online: our current pick

SwissChems sells TB-500 in 2, 5 and 10 mg vials (singly or as 10-vial kits) and a BPC-157 + TB-500 blend (5 + 5 mg or 10 + 10 mg), as freeze-dried powder. Why it is our pick:

  • Lab reports. SwissChems publishes lot-specific certificates of analysis on its independent test results page (131 reports were listed when we checked on 30 October 2026). Each report names the product, the lot and the lab. The report we opened, for GW-501516 (cardarine) lot J26CYG, was issued by Freedom Diagnostics Testing on 3 October 2026 and shows identity confirmed by LC-MS and 99.79% purity by HPLC.
  • Peptide reporting. Its FAQ says freeze-dried peptides are reported with an exact purity figure, and blends are assessed on identity and the content of each component.
  • Storage advice. It recommends keeping vials sealed and away from light, refrigerated for active use and frozen for long-term storage. Bacteriostatic water is not included.
  • Shipping. Shipping, per its shipping page: US orders go by USPS (3–5 business days flat rate, 5–7 days on free shipping) or FedEx Overnight / 2-Day for eligible addresses; international orders go by USPS (2–3 weeks, 1–2 weeks to Canada). Orders ship Monday to Friday, and free shipping starts at $100 in the US and $300 internationally.

The blend: BPC-157 + TB-500 at SwissChems. More on the shop: SwissChems review.

Conclusion

If you are going to buy TB-500, buy from a seller whose lab report confirms the identity of the lot you receive, and go in knowing that what it does in people has not yet been studied. Read our TB-500 fact sheet and BPC-157 review first.

Frequently asked questions

Where can I buy TB-500 online?

Current pick: SwissChemsEvidence: Limited

It is sold by research-peptide shops. The current pick, SwissChems, sells TB-500 in 2, 5 and 10 mg vials and a BPC-157 + TB-500 blend, with lot-specific lab reports.

Read the full section

What dose of TB-500 have studies used?

None established in peopleEvidence: Limited

There is no completed human study of TB-500, so no dose has been established in people. Doses quoted online come from user reports.

Read the full section

Is TB-500 the same as thymosin beta-4?

NoEvidence: Limited

TB-500 is a synthetic fragment based on thymosin beta-4. Human trials of full-length thymosin beta-4 (as eye drops or infusions) don't show how TB-500 behaves.

Read the full section

Is TB-500 banned in sport?

Yes, at all timesEvidence: Law

Thymosin beta-4 and its derivatives, including TB-500, are prohibited at all times under section S2 of the WADA Prohibited List.

How should TB-500 be stored?

Sealed, dark and coldEvidence: Limited

Sealed, protected from light, refrigerated for short-term use and frozen for long-term storage, avoiding repeated freeze–thaw cycles, according to SwissChems' storage guidance.

Read the full section

Sources

  1. FDA Briefing Document, Pharmacy Compounding Advisory Committee, 23–24 July 2026: TB-500-related bulk drug substances 2026
  2. FDA Briefing Document, Pharmacy Compounding Advisory Committee, 23–24 July 2026: BPC-157-related bulk drug substances 2026
  3. ClinicalTrials.gov NCT07487363: Phase 1/2 study of TB-500 (thymosin beta 4 17-23 fragment) in stable atherosclerotic cardiovascular disease 2026
  4. 0.1% RGN-259 (Thymosin ß4) ophthalmic solution promotes healing and improves comfort in neurotrophic keratopathy patients in a randomized, placebo-controlled, double-masked phase III clinical trial 2022 · PMID 36613994
  5. A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteers 2010 · PMID 20536472
  6. Simultaneous quantification of TB-500 and its metabolites in in-vitro experiments and rats by UHPLC-Q-Exactive orbitrap MS/MS and their screening by wound healing activities in-vitro 2024 · PMID 38382158
  7. WADA Prohibited List 2026 2025
  8. SwissChems: Independent test results (lot-specific lab reports) 2026
  9. SwissChems: FAQs (lab testing, purity and variance) 2026